Interventional Management of Stroke (IMS) Study.

Trial Profile

Interventional Management of Stroke (IMS) Study.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Dec 2015

At a glance

  • Drugs Alteplase (Primary) ; Alteplase (Primary)
  • Indications Embolism and thrombosis; Stroke
  • Focus Therapeutic Use
  • Acronyms IMS
  • Most Recent Events

    • 18 Jul 2012 Actual end date (May 2007) added as reported by ClinicalTrials.gov.
    • 12 May 2009 Additional lead trial centre (National Institute of Neurological Disorders and Stroke) and lead trial investigators (Broderick JP, Tomsick TA) added as reported by ClinicalTrials.gov
    • 04 Jun 2007 Status changed from in progress to completed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top